Effect of Foot Reflexology on Preeclampsia

NCT05888896 | Unknown

• 1 other identifier: p.t.REC/012/003568
• Study Type: interventional
• Target: 60
• Locations: 1 country
• Sites: 1

Brief Summary

the aim of this study to investigate the effect of foot reflexology on mild preeclampsia during pregnancy

Conditions

Mild Pre-eclampsia

Keywords

Foot reflexology - Preeclampsia - Proteinuria

Outcome Measures

Primary Outcomes (1)

• Mean arterial blood pressure

  the scale that will be used; the Mercury Pressure and Stethoscope; each patient will measured blood pressure before and after treatment

  8 weeks

Secondary Outcomes (3)

• Overall quality of life questionnaire

  8 weeks

• Serum cortisol

  8 weeks

• Proteinuria

  8 weeks

Study Arms (2)

anti-hypertensive drugs

EXPERIMENTAL

Methyldopa tablets 250 mg will be used oral to reduce hypertension

Other: methyldopa tablets 250mg

anti-hypertensive drugs+foot reflexology

EXPERIMENTAL

Methyldopa tablets 250 mg and foot reflexology sessions for 8 weeks ( 30 min 2 times per week) will be used to reduce hypertension

Other: methyldopa tablets 250mg + foot reflexology

Interventions

methyldopa tablets 250mg OTHER

patients will be taken methyldopa tablets 250mg in the morning orally with a lot of water after breakfast daily and this medication continues for 8 weeks

Also known as: anti-hypertensive drugs

anti-hypertensive drugs

methyldopa tablets 250mg + foot reflexology OTHER

patients will receive methyldopa tablets 250mg in oral way once daily per 8 weeks and patients will receive foot reflexology two sessions per week, every session will last for 30 minutes and sessions will last for 8 weeks.

Also known as: anti-hypertensive drugs+ foot massage

anti-hypertensive drugs+foot reflexology

Eligibility Criteria

• Age: 20 Years - 36 Years
• Gender Eligibility Details: pregnant female with preeclampsia
• Healthy Volunteers: No
• Age Groups: Adult (18-64)

You may qualify if:

• Their ages were ranged between 20-36 years old.
• Their body mass index was not exceeding 35 kg/m2.
• All women were diagnosed as mild preeclampsia.
• All women were primipara and multipara.

You may not qualify if:

• Any fractures in foot.
• Foot ulcer \& infection.
• Open skin wound in foot.
• History of stroke.
• Women less than 20 years and more than 36 years.
• BMI more than 35 Kg\\m2.
• Severe preeclampsia.

Sponsors & Collaborators

• Cairo University: lead

Study Sites (1)

Abeer Ali Ahmed Mansour

Asyut, Assuit, 71511, Egypt

RECRUITING

MeSH Terms

Interventions

Methyldopa; Antihypertensive Agents

Intervention Hierarchy (Ancestors)

Dihydroxyphenylalanine; Catecholamines; Amines; Organic Chemicals; Catechols; Phenols; Benzene Derivatives; Hydrocarbons, Aromatic; Hydrocarbons, Cyclic; Hydrocarbons; Phenylalanine; Amino Acids, Aromatic; Amino Acids, Cyclic; Amino Acids; Amino Acids, Peptides, and Proteins; Tyrosine; Cardiovascular Agents; Therapeutic Uses; Pharmacologic Actions; Chemical Actions and Uses

Central Study Contacts

Abeer Ali, lecturer

CONTACT

01142602929; abeer_ali96@yahoo.com

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: DOUBLE
• Who Masked: PARTICIPANT, OUTCOMES ASSESSOR
• Masking Details: double( Participants, outcomes Assessor)
• Purpose: TREATMENT
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Principal Investigator

Model Details: anti-hypertensive drugs and foot reflexology

Study Record Dates

• First Submitted: May 25, 2023
• First Posted: June 5, 2023
• Study Start: June 9, 2023
• Primary Completion: August 9, 2023
• Study Completion: September 20, 2023
• Last Updated: September 21, 2023

Record last verified: 2023-06

Locations

EG (1)